Differentiated Progeny of Clonal Progenitor Cell Lines
AssigneeBioTime, Inc.
InventorsMichael West, Karen Chapman, Hal Sternberg, Francois Binette
Life of this patent
Estimating the term…
Abstract
Aspects of the present invention include methods and compositions related to the production and use of embryonic progenitor cell types useful in the generation of cartilage, bone, choroid plexus, tendon, lipasin-secreting adipocytes, and other differentiated cell types useful in research and therapy.
Claims29
A method of differentiating a human clonal progenitor cell into an osteochondral cell comprising contacting the human clonal progenitor cell with one or more TGFβ superfamily members.
A cellular composition comprising a hydrogel and the in vitro differentiated progeny of a human clonal progenitor cell, wherein the progeny of the human clonal progenitor cell is an osteochondral cell.
A kit for differentiating human clonal progenitor cells into an osteochondral cell comprising a hydrogel and one or more members of the TGFβ super family.
A cryo-preserved human clonal progenitor cell and a hydrogel.
A cryo-preserved in vitro differentiated progeny of a human clonal progenitor cell and a hydrogel.
Dependencies are inferred from the claim text.